Please login to the form below

Not currently logged in
Email:
Password:

chronic pain

This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.

Lilly, Pfizer say NGF drug works in back pain too

Lilly, Pfizer say NGF drug works in back pain too

Eli Lilly and Pfizer have another positive phase 3 trial for their nerve growth factor-targeting drug tanezumab, showing effective pain relief in chronic lower back pain (CLBP). ... In contrast to opioids, which alter pain perception by targeting opioid

Latest news

  • Medicinal cannabis firm Althea enters UK market Medicinal cannabis firm Althea enters UK market

    The list doesn’t include chronic pain, which is thought to be one of the main drivers for medicinal use of cannabis, and campaigners such as the End Our Pain group

  • The Final Frontier The Final Frontier

    They sent questionnaires to households asking about self-reported pain frequency, intensity and persistency. ... Depending on how you interpret the results, anywhere from 19-44% of Canadians self-report as being afflicted with chronic pain.

  • Medical cannabis now available on prescription, for some Medical cannabis now available on prescription, for some

    But it can’t be prescribed for chronic pain. From today, medicinal cannabis products can legally be prescribed in the UK for the first time, although campaigners say many patients who ... The list doesn’t include chronic pain, however, which is

  • Alnylam seeks fast-track filing with biomarker data Alnylam seeks fast-track filing with biomarker data

    The interim analysis included 43 patients who were on study for at least three months, and looked to reduce AHPs, which involve debilitating neurovisceral attacks as well as chronic pain and

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for post-operative pain management. ... Studies suggest that that one in 10 patients in the US become addicted or dependent on opioids following surgery, adding to their

More from news
Approximately 2 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Tools for the digital world Tools for the digital world

    HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.

  • Pursuing better outcomes for people with pain Pursuing better outcomes for people with pain

    Using the patient’s voice to change how we conduct R&D. Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits ... for chronic pain conditions.”.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression ... With one in five European adults affected by

  • Deal Watch January 2016 Deal Watch January 2016

    Focusing on development for chronic pain, Quartet will receive a $20m fee (representing the upfront and milestones) to cover development through to phase IIa. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions. ... Cara Therapeutics has a chronic pain treatment based on a peptide that

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Dissecting adherence to personalise patient support

    In another study comparing adherence and non-adherence to a new chronic pain medicine, intentional non-adherers had lower beliefs in the need to use the medication while unintentional non-adherers ... This implies that when chronic pain patients are

  • CES 2017 – Medical Device Top Picks

    Thinfilm smart injector pen. YpsoMate’s smart auto-injector pen is designed for patients who self-administer chronic pain medication.

  • Research Partnership has published a new Living with Chronic Pain market report for 2016

    Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. ... Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients with diabetic neuropathic pain, chronic lower back pain, cancer

  • Virtual reality—a change for the better in medical education

    reductions in subjective ratings of chronic pain have also been reported.[10]  Researchers have hypothesised that VR acts as a non-pharmacologic form of analgesia by influencing emotional and attentional processes ... Virtual reality as a distraction

  • Research Partnership

    Prescription medicines. Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases. ... 260 million people from mainland China now suffer from a chronic disease

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics